An Open-label Extension Study of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis

Enrolling By Invitation
99 years or below
All
1 Location

Brief description of study

This study is the OLE of the Main study currently ongoing. Targeted population are those individuals who completed the original study. Study procedures include physical exams, safety labs, ECGs, breathing tests, and questionnaires.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Medical Research
  • Age: 99 years or below
  • Gender: All
Updated on 02 Jul 2025. Study ID: 23-0600
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Office of Clinical Research